Samsung Medison completes acquisition of AI startup Sonio

Sonio, co-founded by Deepak Prakash, is a leading ultrasound AI software company based in Paris

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, completed the acquisition of Sonio SAS, a leading French ultrasound AI software company. Sonio was co-founded by Indian startup entrepreneur Deepak Prakash, who also is the company’s CTO.

The closing of the transaction was subject to applicable regulatory approvals, notably the approval of the French Ministry of the Economy and Finance. Following the completion of the transaction, Sonio will remain an independent company headquartered in France and will continue its commercial growth independently. 

Sonio Detect, an FDA 510(k) cleared AI assistant, provides accurate feedback on ultrasound examination quality and demonstrates remarkable performance with over 90 per cent sensitivity in recognising fetal ultrasound views. Together with Sonio’s world-class AI expertise, Samsung Medison’s leading-edge ultrasound systems will help bring to market, breakthrough AI-enhanced workflows and accelerate innovation in patient outcomes and quality of prenatal care.

"Together, Samsung and Sonio aim to bring about a transformational shift in prenatal ultrasound examinations that would especially be a game changer in developing regions of the world including India,” Prakash.

Said Yong Kwan Kim, Samsung Medison, CEO, “We have great respect and admiration for what the Sonio team has built in the area of maternal care. Through the acquisition of Sonio, Samsung Medison will continue to deliver upon our promise to improve the quality of people’s lives with technology.”

“Samsung Medison’s established global ultrasound business combined with Sonio’s advanced AI creates an exciting growth opportunity for both sides,” said Cécile Brosset, Sonio CEO and Co-founder.